Catégorie de document : Cervical cancer screening
| E-poster title | Authors | Theme | Affiliations | Link | hf:file_type |
|---|---|---|---|---|---|
| EP_009 Routine Use of Conversational Artificial Intelligence for Cervical Screening Awareness in HIV Care in Low Resource Setting: A CFIR-Guided Exploration | AJAYI Oluseye.a – Nigeria | Cervical cancer screening | O.A. Ajayi (1), L.M. Gaydos (2), O.O. Ogunsola (1), C. Ijeoma (3), A. Sarker (4), L. Flowers (5) | ||
| EP_012 The role of colposcopy in identifying precancerous changes in the cervix | GURBATOVA Nargiz Gurbatova – Azerbaijan | Cervical cancer screening | N.G. Gurbatova | pptx | |
| EP_013 SOX1/PAX1 Methylation Testing for Triage of Cervical Type 3 Transformation Zone (TZ3) | BI Hui – China | Cervical cancer screening | L.Y. Chen, B.B. Xiao, H. Bi | ||
| EP_014 Optimizing HPV Detection in Urine via Ultra-Short Fragment Targeting: A Comparative Study with Cervical Samples | NIU Hanfei – China | Cervical cancer screening | B.X. Xiao, H.N. Niu | ||
| EP_015 The application value of rapid detection of E7 protein in the diagnosis of cervical precancerous lesions | ZHAO Chao – China | Cervical cancer screening | C. Zhao, L. Wei, M. Li, J. Li, W. Zhang, Y. Zhao | ||
| EP_016 HPV negative case-report | CHAPUT Louis – France | Cervical cancer screening | C.R. Rigori, L.C. Chaput, C.G. Gay | ||
| EP_017 Assessment of Acceptability and Clinical Utility of Self-Sampling for HPV Detection in Transgender Men Attending a Gender Clinic in Bogotá, Colombia: A Cross-Sectional Study | MONTENEGRO HERNANDEZ Andrea Carolina – Colombia | Cervical cancer screening | A.C. Montenegro Hernandez (1), L.A.U.R.A. Parra Tellez (2), L.A. Diaz Cruz (3), D.C. Vargas Fiesco (3), J. Amaya Guio (3), L.P. Velez Marin (3), J.A. Robles Duarte (3) | ||
| EP_018 High-Grade Cervical Intraepithelial Lesions: Prevalence and impact of municipality-level social inequalities on the time to obtain a diagnosis and follow-up in the French Cervical Cancer Screening Program. | BALAMOU Christian – France | Cervical cancer screening | C. Balamou (1), K. Zysman (2), C.M. Rodrigue (3), A. Seigneurin (4) | pptx | |
| EP_019 Cervical Screening in low- and middle-income countries: A finalised project in Uganda | GALLEGO DE LARGY Cristina – Spain | Cervical cancer screening | C. Gallego De Largy (1), M. Serrano Velasco (2), M.A. Oyonarte (3), G. Peña Illana (4), T. Mukama (5), D.O. Sara (1) | ||
| EP_020 Spatial and Temporal Mapping of Cervical Lesions Using Cervical Cell Lift: A Two-Year Longitudinal Observation | MIYAZAKI Mai – United Kingdom | Cervical cancer screening | M. Miyazaki (1), N. Egawa (1), A. Shirz (2), A. Nishimura (3), T. Motohara (3), K. Nagasaka (4), R. Crawford (2), J. Doorbar (1) | pptx | |
| EP_021 Invasive Stratified Mucin-Producing Intraepithelial Lesion (iSMILE) in a High-Risk Patient: Diagnostic and Management Challenges | MVUNTA David – South Africa | Cervical cancer screening | D. Mvunta (1), R. Kalunduka (2), J. Chokoe-Maluleke (2), N. Mbatani (1), T. Adams (1) | ||
| EP_023 Neuroendocrine tumor of the uterine cervix | LA VALLE Sofia – Argentina | Cervical cancer screening | S.O.F.I.A. La Valle (1), L.F. Fleider (2), M.S. Spinosa (2), C.A. Alonso (2), F.K. Kamermann (2), L.C. Cardinal (2), A.B. Bermudez (2) | png | |
| EP_027 Performance and limitations of a cervical cancer screening campaign in an urban cameroonian setting : the experience of douala | KAMDEM MODJO Diane Estelle – Cameroon | Cervical cancer screening | D.E. Kamdem Modjo, A. Sango, H.T. N, E.T. Mboudou | ||
| EP_028 Impact of the Introduction of HPV/Pap Co-Testing on the Detection of High-Grade Cervical Dysplasia (CIN II+) in Women Aged 35 and Older: A Study from two German Colposcopy Units | GÜTTLER Soheyla – Germany | Cervical cancer screening | S. Güttler (1), E. Maier (2), F. Stübs (1), M.W. Beckmann (1), G. Mehlhorn (3) | ||
| EP_029 Knowledge, Attitudes and Practices Regarding Cervical Cancer Screening Among Indigenous Women | BELÉM LUNA SAMPAIO Brenda – Brazil | Cervical cancer screening | B. Belém Luna Sampaio (1), C. Mélo Poletto (2), L. Barbosa De Sousa (2), S. De Jesus Silva Bezerra Dos Anjos (1), G. Ferreira Felipe (2), J. Domingos De Morais (2), C. Chaves Da Costa (2) | ||
| EP_032 A six-methylation-marker panel as an effective triage alternative for HPV-positive women: a population-based prospective cohort | YANG Liu – China | Cervical cancer screening | L. Yang, X. Rao, W. Wang, X. Li | ||
| EP_033 Prevalence of Abnormal Cervical Cytology and High-Risk HPV in Older Women with Pelvic Organ Prolapse | OTSUKA Koji – Japan | Cervical cancer screening | K. Otsuka (1), I. Otsuka (1), Y. Kanamoto (1), A. Yoshikawa (2), M. Nomura (3) | ||
| EP_034 Screening for cervical cancer ; An analysis of modalities in a private healthcare setting | ABHYANKAR Bharati – India | Cervical cancer screening | B. Abhyankar | ||
| EP_035 A Portable Soft Robotic Device Enabling Speculum-Free Cervical Assessment and Sampling | MCDONALD-BOWYER Aoife – United Kingdom | Cervical cancer screening | A. Mcdonald-Bowyer (1), A. Gentry-Maharaj (2), O. Adeola (2), S. Danail (1), S. Agostino (1) | ||
| EP_036 High-Risk HPV Testing in ASC-US Cytology: Clinical Outcomes and Implications for Cervical Cancer Prevention | HORIUCHI Akiko – Japan | Cervical cancer screening | A. Horiuchi, S. Horiuchi | ||
| EP_037 Harnessing Machine Learning to Assess Cervical Cancer Health Access | ZHAO Xueying – United States | Cervical cancer screening | X. Zhao (1), W. Leo (2), A. Liu-Ferrara (3) | ||
| EP_038 Comparative Effectiveness of HPV Testing as a Cervical Screening Tool | PINCHUK Tatsiana – Belarus | Cervical cancer screening | T. Pinchuk | ||
| EP_043 Mueller Polarimetric Colposcopy: An Innovative, Label-Free Approach for High-Precision, Real-Time In Vivo Detection of Cervical Precancer | PIERANGELO Angelo – France | Cervical cancer screening | A. Pierangelo (1), E. Le Pennec (2), J. Park (1), I. Kamal (1), E. Debras (3), A. Gandji (3), J.C. Vanel (1), D. Luton (3) | ||
| EP_044 Treating Cervical Cancer While Preserving Pregnancy – A Multidisciplinary Challenge | LIMA MARTINS Andreia – Portugal | Cervical cancer screening | A. Lima Martins, H. Veloso, F. Pacheco, M.J. Carinhas, R. Zulmira Macedo | ||
| EP_045 Three conizations, one diagnosis: the challenge of treating persistent HSIL | BARBOSA Cristiana – Portugal | Cervical cancer screening | C. Barbosa, C. Tavares, M.J. Carinhas | ||
| EP_046 HPV Infection and Cervicovaginal Microbiome Composition in Pregnant women living with HIV | FURTADO Yara Lucia – Brazil | Cervical cancer screening | Y.L. Furtado (1), L. Moura (2), R. Novais (3), L. Letícia (2), M. Soares (2), J. Siqueira (2), L. Goes (4) | ||
| EP_047 Comparative Analysis of HPV Genotyping and Microbiome Profiles in Cervical Samples Obtained by Urine, Self-Collection, and Healthcare ProfessionalsLS | CHIAROT Fernanda – Brazil | Cervical cancer screening | F. Chiarot (1), C.P. Castanheira (2), N.P.C. Lorenzi (3), M. Tacla (4), A. Longatto-Filho (5), E.C. Baracat (6), L.L. Villa (7), G.A.R. Maciel (8), L. Termini (7) | ||
| EP_048 Application of Self-Sampled Cervical Exfoliated Cells for HPV E6/E7 mRNA Detection in Cervical Cancer Screening: A Multicenter Clinical Validation Study | FENGYI Xiao – China | Cervical cancer screening | X. Fengyi, S. Long | ||
| EP_050 Expression profile of immunological panel IL1β, IL10, IL18, TNF-α, TLR4, GATA3, CD68 on cervical samples with positive/negative hr-HPV DNA/E6 E7 mRNA status and cytological estimation. | KAVRAKOVA Anita – Bulgaria | Cervical cancer screening | A. Kavrakova (1), B. Georgieva (2), K. Mesechkova (3), V. Mitev (2), A. Todorova (4) | pptx | |
| EP_051 Advancing Cervical Cancer Elimination in Albania Through Screening and Early Diagnosis | ENKELEDA Prifti – Albania | Cervical cancer screening | P.E. Enkeleda (1), D.N. Nensi (2) | ||
| EP_052 Glandular lesions and AIS – Correlation of abnormal cytology and histological findings | HENES Leon – Germany | Cervical cancer screening | L. Henes (1), E. Mann (2), C. Hirchenhain (3), A. Kentner (4), M. Henes (1), V. Küppers (5) | ||
| EP_053 Diagnostic accuracy of human papillomavirus tests on self-collected menstrual blood for the detection of cervical lesions: a systematic review and meta-analysis | WANG Xibo – China | Cervical cancer screening | X. Ji, X. Wang | ||
| EP_055 Diagnostic Value of HPV Integration Testing in Cervical Adenocarcinoma and Adenocarcinoma in Situ: A Multicenter Retrospective Study | YU Nan – China | Cervical cancer screening | N. Yu, D. Ma, C. Gao | ||
| EP_056 Study on Sampling Methods for Human Papillomavirus (HPV) Detection and the Correlation of HPV Infection Between Female Patients and Their Male Partners | DING Yi – China | Cervical cancer screening | N. Yu, D. Ma, Y. Ding | ||
| EP_057 The role of HPV integration testing in preventing underdiagnosis in women with a transformation zone type 3 | MA Ding – China | Cervical cancer screening | N. Yu, D. Ma, D. Kong | ||
| EP_058 The value of HPV integration testing for detecting cervical precancer or cancer miss-diagnosed by colposcopy-directed biopsies: a cross-sectional study | MA Ding – China | Cervical cancer screening | N. Yu, D. Ma, D. Kong | ||
| EP_060 Follow up a patients with primary ASCUS in Pap test. | BABLOYAN Syuzanna – Armenia | Cervical cancer screening | S. Babloyan (1), L. Stepanyan (2), N. Vardanyan (3) | ||
| PC_001 Regional Distribution and Genomic Mapping of High-Risk Human Papillomavirus Genotypes in Central Mexico: A Population-Based Study from Aguascalientes | FLOTA Diego – Mexico | Cervical cancer screening | D. Flota (1), O. Camarillo (2), L. Hernandez (1), K. Sigala (1), C. Sanchez (1) | pptx | |
| PC_003 Turning Awareness in Action: Understanding Facilitators and Barriers to Cervical Cancer Screening, Insights from the CASCADE “CN001” Study | LYMON Kadera – United States | Cervical cancer screening | K. Lymon (1), M.G. Tadros (1), K. Cho (1), L. Flowers (1), C. Mehta (2), N. Kaonga (1), L. Gaydos (3), A. Sheth (4), M.L.T. Nguyen (2), V. Sahasrabudhe (5) | pptx | |
| PC_006 Evaluation of HR-HPV genotyping in urine: comparison with cervical swabs and time-of-day effects | NIU Hanfei – China | Cervical cancer screening | B.X. Xiao, H.N. Niu | pptx | |
| PC_007 Clinical Utility of a Rapid E7 Oncoprotein POCT Assay as a Functional Triage for HR-HPV Positive Women: A Dual-Center Study | YANG Maolin – China | Cervical cancer screening | W.Z.H.A. Zhao (1), M.Y.A.N. Yang (2), J.M.A. Ma (1) | pptx | |
| PC_008 Geographic inequalities from High-Grade Cervical Intraepithelial Lesions to Cervical Cancer in Isère, France | BALAMOU Christian – France | Cervical cancer screening | C. Balamou (1), C.M. Rodrigue (2), K. Zysman (3), A. Seigneurin (4) | pptx | |
| PC_009 Clinical Significance of Atypical Glandular Cells on Cervical Cytology | SPINOSA Mercedes – Argentina | Cervical cancer screening | M.S. Spinosa (1), S.O.F.I.A. La Valle (2), C.A. Alonso (2), L.F. Fleider (2), C.S. Salamanca (2) | pptx | |
| PC_010 Sensitivity and Specificity of a complete real-time PCR genotyping, identifying 19 high-risk (HR) and 9 low-risk (LR) HPV types for CIN2+ Detection | FLEIDER Laura – Argentina | Cervical cancer screening | L.F. Fleider, M.D.L.A. Tinnirello, L.G. Gallo Vaulet, A.T. Toledano, A.P. Puñal, C.A. Alonso, J.G. Giarmana, S.L. La Valle, M.R.F. Rodriguez Fermepin, J. Ortiz | pptx | |
| PC_014 Histological Yield of HR-HPV Positive, Cytology-Negative Referrals to Colposcopy in a Model 3 Hospital in Ireland | NAZIR NAZIR Sofia Ruth – Ireland | Cervical cancer screening | S.R. Nazir Nazir (1), S. Jaleel (1), H. Elves (2), E. Mccole (2), K. Khan (1), M. Collins (2), M. Gardasanic (1) | pptx | |
| PC_015 Sustaining and scaling HPV-based cervical screening in hospital-based antenatal care: an implementation evaluation | DIXON Jordan – Australia | Cervical cancer screening | J. Dixon (1), A. Machado Colling (1), C. Nightingale (1), D. Rolnik (2), D. Hawkes (3), M. Saville (3), A. Bastable (4), M. Smith (5), J. Brotherton (1) | pptx | |
| PC_016 Determining the genetic risk for cervical cancer | MINAEVA Anastasia – Russia | Cervical cancer screening | A. Minaeva (1), M. Vinokurov (2), G. Leshkina (2), K. Mironov (2), A. Efimova (1) | pptx | |
| PC_017 Determinants of Non-Participation in Cervical Cancer Screening by Human Papilloma Virus Self-Sampling among Urban Women in Mumbai, India. | PIMPLE Sharmila – India | Cervical cancer screening | S. Pimple (1), D. Thiruvengadam (2), G. Mishra (3), A. Maheshwari (4), S. Biswas (4), K. Prasad (5) | pptx | |
| PC_019 Psychological Parameters in Individuals with a Positive HPV Test and Normal Cytology (Pap I or IIa) Compared to Individuals with a Negative or Unknown HPV Status (HAPPI study) | REENTS Wenke – Germany | Cervical cancer screening | W. Reents (1), A. Hildebrandt (1), M. Schild-Suhren (2), A. Lindig (1) | pptx | |
| PC_020 Multiple Dimensions of Social Vulnerability and Cervical Cancer Screening Uptake: A cohort Study | HAURY Julie – France | Cervical cancer screening | J. Haury (1), S. Crequit (2), G. Canlorbe (1), B. Renevier (2) | pptx | |
| PC_021 Co-designing the ideal cervical screening program with and for people with disability | HOFLER Nicola – Australia | Cervical cancer screening | M. Galrao, F. Townsend, N. Hofler | pptx | |
| PC_023 Accuracy of HPV DNA Methylation tests in the Triage of High-Risk HPV–Positive Women | PCOLKINA Kristine – Latvia | Cervical cancer screening | K. Pcolkina (1), O. Plisko (2), I. Jermakova (1), D. Araja (1), D. Kunicina (1), A. Cerneikina (3), Z. Daneberga (3), J. Zodzika (4) | pptx | |
| PC_024 HPV Viral Load: A Potential Biomarker for Diagnosis and Clinical Monitoring | CHIAROT Fernanda Dahrouge – Brazil | Cervical cancer screening | F.D. Chiarot, V.R. Silva, J.L. Cunha, L.Z. Renaldi | pptx | |
| PC_025 The Diagnoses Value of Hypermethylated PCDHGB7 MSRE-qPCR in Endocervical Gastric-type Adenocarcinoma | ZHONG Fangfang – China | Cervical cancer screening | F. Zhong (1), W. Li (2), X. Tang (3), Z. Ren (1), S. Ji (4), W. Yu (2), W. Wang (3), X. Tao (1), C. Zhao (5) | pptx | |
| PC_026 Microbiome and metabolomic changes associated with HPV clearance in women undergoing local excisional treatment for cervical intraepithelial neoplasia | PU Xiaowen – China | Cervical cancer screening | X. Pu (1), J. Wang (1), Z. Gu (1), C. Li (2) | ||
| PC_028 Acceptability of HPV Self-Sampling Among Women Referred for Colposcopy in Singapore | TAN Marie Min Tse – Singapore | Cervical cancer screening | M.M.T. Tan (1), B.Z. Tok (1), H.G. Chan (2), W.Y. Lee (3), L.E.L. Oon (3), S.K. Tay (3), J.X. Ang (3) | pptx | |
| PC_030 Perceived barriers and facilitators to cervical screening among physically Disabled women in the UK: qualitative findings from a cross-sectional survey | WRIGHT-BEVANS Katie – United Kingdom | Cervical cancer screening | E. Kemp (1), K. Wright-Bevans (2), J. Sim (2), C. Chew-Graham (2), A. Finney (2), C. Harper (2), L. Marlow (3), S. Renke (4), S. Sherman (1) | pptx | |
| PC_032 Cervical adenocarcinoma in situ – from primary screening, diagnosis, and treatment to follow-up: A retrospective study | GUO Yulin – China | Cervical cancer screening | Y. Guo, X. Wu | pptx |